Pharmacokinetic Study Comparing Area Under the Curve for a Single Dose of Venlafaxine ER Pre- and Post-gastric Bypass

Trial Profile

Pharmacokinetic Study Comparing Area Under the Curve for a Single Dose of Venlafaxine ER Pre- and Post-gastric Bypass

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Aug 2017 Primary endpoint (Venlafaxine levels pre- and post-gastric bypass) has not been met as per the results published in the Pharmacotherapy
    • 28 Aug 2017 Results published in the Pharmacotherapy
    • 29 Sep 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top